James Gordon
As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.
Psychedelic-assisted therapy commonly involves experiences of self-love, love towards others, love received, and being in love. Research explores these experiences' healing potential and integration in therapy.
Panel of experts explores psychedelics' role in conflict resolution, restorative justice, and peace-building. Discussion includes research, experiences, and ethical considerations for integrating psychedelics into transformative processes.
Psychedelic-induced states are compared to psychosis in a talk examining perceptions and impacts on individuals with a history of psychosis who have used psychedelics. The study explores both negative and
Haley Maria Dourron
Psilocybin's therapeutic potential for mental health is being studied for its mechanisms and optimal therapeutic window. Research investigates brain changes during and after psilocybin experiences in healthy volunteers.
Jessica L Nielson
Panelists from Zendo Project, Fireside Project, Kosmicare, and Anashim Tovim discuss harm reduction strategies in the psychedelic ecosystem, emphasizing innovation, compassion, and scientific expertise in diverse settings. They provide case
Joshua White, Daniel E Martin, Pinni Baumol, Shirelle Noble, Ben Halper
Psychedelics are studied for psychiatric disorders; research emphasizes 'set and setting.' Study explores psychosocial factors in psychedelic use, linking communal experiences to improved mental health outcomes.
Hannes Kettner
Stanislav Grof, a pioneer in psychedelic research, presents the Grof® Legacy Training on 'holotropic' states of consciousness, with colleagues from international psychedelic training programs.
Brigitte Grof, Stanislav Grof, Diane Haug, Javier Charme, Neil Hannon, Jay Dufrechou
The POIESIS study explores how self-identity dimensions influence preferences in a psychedelic dosing environment. Initial findings show stronger connections to spiritual/religious identity compared to racial/ethnic identity. Ongoing efforts aim to
Cody J Wenthur
Psychedelic research faces challenges balancing methodological rigor with preserving subjective experiences in clinical trials, aiming to avoid bias while capturing the full impact of psychedelics on participants.
Ingmar Gorman, Erika Dyck, Tehseen Noorani